Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT: LMWH vs Aspirin in Orthopedic Trauma
NCT02774265Phase 3Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jan 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in venous thromboembolism (VTE), sponsored by University of Maryland, Baltimore. Started Jan 2016; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02774265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774265.